Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ProQR Therapeutics N.V. AGM Information 2021

Apr 20, 2021

33579_ffr_2021-04-20_83709713-50fc-47a8-9e6f-a8a96249afc5.zip

AGM Information

Open in viewer

Opens in your device viewer

6-K 1 tm2113422d1_6k.htm FORM 6-K

Field: Rule-Page

Field: /Rule-Page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934

For the month of April 2021

Commission File Number: 001-36622

PROQR THERAPEUTICS N.V.

Zernikedreef 9

2333 CK Leiden

The Netherlands

Tel: +31 88 166 7000

(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F x Form 40-F ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ¨

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ¨

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

On April 20, 2021, ProQR Therapeutics N.V. issued a press release announcing its 2021 annual general meeting of shareholders, which will be held virtually via videoconference, and made available to its shareholders certain other materials in connection with such meeting.

Such materials are attached as exhibits to this Report of Foreign Private Issuer on Form 6-K and are incorporated by reference herein.

Field: Page; Sequence: 2

Field: /Page

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

/s/ Smital Shah
Smital Shah
Chief Financial Officer

Field: Page; Sequence: 3

Field: /Page

INDEX TO EXHIBITS

Number Description
99.1 Press Release of ProQR Therapeutics N.V. dated April 20, 2021.
99.2 Notice of the 2021 Annual General Meeting of Shareholders
99.3 Explanatory Notes to the Agenda of the 2021 Annual General Meeting of Shareholders
99.4 Proxy Form

Field: Page; Sequence: 4; Options: Last

Field: /Page